Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature
ConclusionsMalignant melanoma may display neuroendocrine differentiation, and the entity should be considered a rare differential diagnosis when assessing biopsies of suspected neuroendocrine carcinomas.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Carcinoma of Unknown Primary | Chemotherapy | General Medicine | Melanoma | Neurology | Skin Cancer